GE Healthcare Partners With China’s BGI For Stem Cell Drug Discovery
This article was originally published in PharmAsia News
The partners will examine the underlying genetic variation between ethnically diverse human stem cells, which can give scientists a more precise picture of the effect of a certain therapy compared to animal models.
You may also be interested in...
After announcing the intent to form a partnership a year ago, Merck & Co. announced Sept. 13, a collaboration with BGI (formerly the Beijing Genomics Institute) for discovery and development of biomarkers and genomic technologies
Shiseido has strategic initiatives planned for its domestic and Chinese businesses and Bare Escentuals in the U.S. following a disappointing fiscal 2012 in which the Toyko-based firm recorded a net loss of $148 million.
La Bella, L.A. Looks and Soft & Dri have new websites and new marketing strategies behind them as Newhall Laboratories endeavors to rejuvenate personal-care brands it’s acquired over the past year and a half.